NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3025% above fair value
$8.20+0.23 (+2.89%)
Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%
NeuroPace profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NeuroPace's profit margin for the twelve months ending Jun 30, 2026 was -19.3%. For fiscal 2025 it was -21.5%, against -34.0% the year before. The highest annual figure on record is -21.5% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -21.5% | +12.5 |
| FY2024 | Dec 31, 2024 | -34.0% | +16.4 |
| FY2023 | Dec 31, 2023 | -50.4% | +53.1 |
| FY2022 | Dec 31, 2022 | -103.4% | −23.6 |
| FY2021 | Dec 31, 2021 | -79.9% | −20.8 |
| FY2020 | Dec 31, 2020 | -59.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -27.2% | +17.2 |
| Q1 FY2026 | Mar 31, 2026 | -30.3% | −1.1 |
| Q4 FY2025 | Dec 31, 2025 | -10.3% | +14.2 |
| Q3 FY2025 | Sep 30, 2025 | -12.8% | +13.1 |
| Q2 FY2025 | Jun 30, 2025 | -44.4% | −5.3 |
| Q1 FY2025 | Mar 31, 2025 | -29.3% | +20.0 |
| Q4 FY2024 | Dec 31, 2024 | -24.5% | +10.0 |
| Q3 FY2024 | Sep 30, 2024 | -25.9% | +18.3 |
| Q2 FY2024 | Jun 30, 2024 | -39.0% | +16.2 |
| Q1 FY2024 | Mar 31, 2024 | -49.2% | +22.4 |
| Q4 FY2023 | Dec 31, 2023 | -34.4% | +52.7 |
| Q3 FY2023 | Sep 30, 2023 | -44.2% | +61.5 |
| Q2 FY2023 | Jun 30, 2023 | -55.3% | +69.1 |
| Q1 FY2023 | Mar 31, 2023 | -71.7% | +29.1 |
| Q4 FY2022 | Dec 31, 2022 | -87.2% | +10.1 |
| Q3 FY2022 | Sep 30, 2022 | -105.6% | −27.4 |
| Q2 FY2022 | Jun 30, 2022 | -124.4% | −57.2 |
| Q1 FY2022 | Mar 31, 2022 | -100.8% | −22.2 |
| Q4 FY2021 | Dec 31, 2021 | -97.2% | −54.3 |
| Q3 FY2021 | Sep 30, 2021 | -78.2% | −45.9 |
| Q2 FY2021 | Jun 30, 2021 | -67.3% | +47.8 |
| Q1 FY2021 | Mar 31, 2021 | -78.5% | −11.0 |
| Q4 FY2020 | Dec 31, 2020 | -43.0% | – |
| Q3 FY2020 | Sep 30, 2020 | -32.3% | – |
| Q2 FY2020 | Jun 30, 2020 | -115.1% | – |
| Q1 FY2020 | Mar 31, 2020 | -67.6% | – |
See a number that looks wrong?